Remote Patient Monitoring of Patients on CAR T-Cell Therapy — [PODCAST] EP 95

While remote monitoring platforms have been used effectively throughout the COVID-19 pandemic to reduce the burden on patients and healthcare facilities around the country, Vanderbilt Ingram Cancer Center in Nashville, Tenn., has been using the technology in a different capacity—with its chimeric antigen receptor (CAR) T-cell therapy patients. Today, these patients are monitored 24/7 via remote technology, alerting cancer program staff of any significant changes in clinical status that would initiate a hospital admission.

Read more in "Changing the Tune for CAR T-Cell Therapy: A Music City Experience in Remote Patient Monitoring," in the Volume 38, Number 6 Oncology Issues.

Guest:

Brittney M. Baer, BSN, RN

Patient Care Coordinator

Vanderbilt University Medical Center

“One of the biggest challenges is access to care for CAR T-cell therapy patients...it’s a struggle for them [patients] to get to these larger academic medical centers and that’s a burden on patients…so, it’s very, very cool and our patients seem to really enjoy it because they don’t have to spend nearly as much time at the hospital.”

Resources:

• Bringing CAR T-cell Therapy to Community Oncology Overview
• CAR T-cell Practice Profile – Fox Chase Cancer Center
• CAR T-cell Practice Profile – Billings Clinic Cancer Center
• Gap Analysis: Bringing CAR T-cell Therapy to Community Oncology
• IO Insight: Telemedicine and Cancer Care